Stocks of Aquestive Therapeutics Inc (NASDAQ:AQST) traded higher last session on Wall Street, up 0.39% to $2.60.
AQST stock price is now -18.18% away from the 50-day moving average and -4.47% away from the 200-day moving average. The market capitalization of the company currently stands at $236.70M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $8, Leerink Partners recently initiated with Outperform rating for Aquestive Therapeutics Inc (NASDAQ: AQST). On April 11, 2024, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $10, while ‘Raymond James’ rates the stock as ‘Outperform’
In other news, Schobel Alexander Mark, Chief Innovation/Tech Officer sold 50,000 shares of the company’s stock on Mar 15 ’24. The stock was sold for $300,000 at an average price of $6.00. Upon completion of the transaction, the Chief Innovation/Tech Officer now directly owns 984,476 shares in the company, valued at $2.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 08 ’24, Chief Innovation/Tech Officer Schobel Alexander Mark sold 25,000 shares of the business’s stock. A total of $129,685 was realized by selling the stock at an average price of $5.19. This leaves the insider owning 1,040,371 shares of the company worth $2.7 million. A total of 12.40% of the company’s stock is owned by insiders.
During the past 12 months, Aquestive Therapeutics Inc has had a low of $1.25 and a high of $6.23. The fifty day moving average price for AQST is $3.1512 and a two-hundred day moving average price translates $2.726225 for the stock.
The latest earnings results from Aquestive Therapeutics Inc (NASDAQ: AQST) was released for 2024-03-31. The company reported revenue of $12.05 million for the quarter, compared to $11.13 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.25 percent.
